AnalystsDerik De BruinDerik De Bruin's Stock Forecasts
AnalystsDerik De Bruin
Analyst Ranking
Top 6%
#228 out of 4126 analysts
Average Return
+15.41%
Win Rate
67%32 out of 48
Risk vs Reward
Poor
Good
Derik De Bruin's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Exact Sciences CorpEXAS | +122.87% | $51.63 | $115.07 | 2018-08-02 - 2019-08-02 | Strong Buy |
Hologic IncHOLX | +118.26% | $34.06 | $74.34 | 2020-04-02 - 2021-04-01 | Strong Buy |
Talis Biomedical CorpTLIS | +83.23% | $3.31 | $0.56 | 2022-01-07 - 2022-12-02 | Sell |
Iqvia Holdings IncIQV | +78.91% | $141.94 | $253.94 | 2020-07-07 - 2021-07-07 | Strong Buy |
Exact Sciences CorpEXAS | +77.58% | $65.96 | $117.13 | 2018-07-23 - 2019-07-23 | Strong Buy |
Derik De Bruin's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Icon PLCICLR | 1 | Strong Buy | $260.00 | +22.03% | Upgrades | a month ago |
Catalent IncCTLT | 4 | Hold | $60.00 | +14.83% | Downgrades | a month ago |
West Pharmaceutical Services IncWST | 3 | Hold | $250.00 | +2.31% | Downgrades | a month ago |
Agilent Technologies IncA | 3 | Strong Buy | $155.00 | -0.43% | Maintains | 4 months ago |
Perkinelmer IncPKI | 3 | Hold | $178.00 | +27.85% | Downgrades | 4 months ago |
Hologic IncHOLX | 5 | Hold | $75.00 | -1.96% | Downgrades | 5 months ago |
10x Genomics IncTXG | 3 | Sell | $35.00 | -10.19% | Downgrades | 5 months ago |
Ginkgo Bioworks Holdings IncDNA | 3 | Sell | $3.00 | +50.75% | Downgrades | 7 months ago |
Waters CorpWAT | 4 | Hold | $330.00 | -5.00% | Upgrades | 7 months ago |
Exact Sciences CorpEXAS | 4 | Strong Buy | $95.00 | +104.92% | Maintains | 7 months ago |
Quest Diagnostics IncDGX | 2 | Strong Buy | $163.00 | +8.33% | Maintains | 7 months ago |
Talis Biomedical CorpTLIS | 3 | Sell | $1.50 | +170.27% | Maintains | 9 months ago |
Stevanato Group SpaSTVN | 1 | Strong Buy | $24.00 | +50.00% | Maintains | 9 months ago |
Illumina IncILMN | 3 | Hold | $390.00 | +78.28% | Upgrades | a year ago |
Zymergen IncZY | 1 | Sell | $7.00 | N/A | Downgrades | a year ago |
Lucira Health IncLHDX | 1 | Sell | $9.00 | N/A | Downgrades | 2 years ago |
Qiagen NvQGEN | 2 | Strong Buy | $59.00 | N/A | Upgrades | 2 years ago |
Laboratory Corp Of America HoldingsLH | 1 | Strong Buy | $220.00 | N/A | Upgrades | 2 years ago |
Iqvia Holdings IncIQV | 1 | Strong Buy | $156.00 | N/A | Maintains | 2 years ago |
Neogenomics IncNEO | 1 | Strong Buy | $34.00 | N/A | Initiates Coverage On | 2 years ago |
Myriad Genetics IncMYGN | 3 | Sell | $13.00 | N/A | Reiterates | 3 years ago |
Mettler Toledo International IncMTD | 3 | Hold | N/A | N/A | Downgrades | 4 years ago |
Idexx Laboratories IncIDXX | 2 | Strong Buy | $235.00 | N/A | Maintains | 4 years ago |
Zoetis IncZTS | 1 | Strong Buy | $100.00 | N/A | Maintains | 4 years ago |
Charles River Laboratories International IncCRL | 2 | Strong Buy | $125.00 | N/A | Maintains | 4 years ago |
Bruker CorpBRKR | 1 | Hold | $34.00 | N/A | Maintains | 5 years ago |
Abaxis IncABAX | 3 | Sell | $48.00 | N/A | Maintains | 5 years ago |
Thermo Fisher Scientific IncTMO | 1 | Strong Buy | $250.00 | N/A | Maintains | 5 years ago |
3d Systems CorpDDD | 1 | Sell | N/A | N/A | Downgrades | 5 years ago |
Phibro Animal Health CorpPAHC | 1 | Sell | $33.00 | N/A | Reinstates | 5 years ago |
Pra Health Sciences IncPRAH | 1 | Strong Buy | $89.00 | N/A | Initiates Coverage On | 5 years ago |
©2022 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.